Skip to main content
All lobbying filings

NOVAVAX, INC

NOVAVAX, INC filed a Q2 report for NOVAVAX, INC on July 17, 2026.

Lobbying for NOVAVAX, INC

All filings by NOVAVAX, INC · Everything NOVAVAX, INC has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 17, 2026
Expenses
$130,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Maryland

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Issues related to federal vaccine programs and vaccine regulatory frameworks

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem